Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $33.86 Stock is Down 0.67 (1.94%)09/22/17 2:12 p.m. ET
Stock chart for: ANAB.O.  Currently trading at $33.86 with a 52 week high of $37.62 and a 52 week low of $15.17.
Data provided by Nasdaq. Minimum 15 minutes delayed.




Upcoming Events


  |   |   |   |   |